Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018;35(1):2-4.
doi: 10.36141/svdld.v35i1.7032. Epub 2018 Apr 28.

New advances in the development of sarcoidosis models: a synopsis of a symposium sponsored by the Foundation for Sarcoidosis Research

Jacobo Sellares  1   2   3 , Irina Strambu  4 , Elliot D Crouser  5 , Marina A Freudenberg  6 , Mridu Gulati  7 , Simon Hart  8 , Erika Herzog  7 , Martin Kolb  9 , Thomas Weichhart  10 , Wonder P Drake  11 , Ginger Spitzer  12 , Noopur Singh  12 , Daniel A Culver  13
Affiliations
Editorial

New advances in the development of sarcoidosis models: a synopsis of a symposium sponsored by the Foundation for Sarcoidosis Research

Jacobo Sellares et al. Sarcoidosis Vasc Diffuse Lung Dis. 2018.

Abstract

Sarcoidosis is a complex disease with variable phenotypes that will require a multisystem approach to understand pathophysiology. One of the most challenging problems in sarcoidosis research is the absence of valid and widely accepted experimental models that accurately simulate human disease. The Foundation of Sarcoidosis Research (FSR) has funded five projects for the development of novel experimental models for sarcoidosis, presented and discussed in a workshop organized during the European Respiratory Society Congress held in Milan from September 9th to 13th. The experimental, in vivo or in sillico models presented may be quite helpful for investigating specific pathogenic and therapeutic questions, addressing especially severe forms of sarcoidosis. (Sarcoidosis Vasc Diffuse Lung Dis 2018; 35: 2-4).

Keywords: models; pathogenesis; sarcoidosis.

PubMed Disclaimer

References

    1. Jeny F, Pacheco Y, Besnard V, Valeyre D, Bernaudin JF. Experimental models of sarcoidosis. Curr Opin Pulm Med. 2016;22:492–499. - PubMed
    1. Sauer WH, Stern BJ, Baughman RP, Culver DA, Royal W. High-Risk Sarcoidosis. Current Concepts and Research Imperatives. Ann Am Thorac Soc. 2017;14:S437–S444. - PubMed
    1. Antoniu SA, Kolb MR. Update on models of pulmonary fibrosis therapy for preclinical drug research. Expert Opin Drug Discov. 2009;4:939–946. - PubMed
    1. Jenkins RG, Moore BB, Chambers RC, Eickelberg O, Königshoff M, Kolb M, Laurent GJ, Nanthakumar CB, Olman MA, Pardo A, Selman M, Sheppard D, Sime PJ, Tager AM, Tatler AL, Thannickal VJ, White ES. ATS Assembly on Respiratory Cell and Molecular Biology. An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2017;56:667–679. - PMC - PubMed
    1. Crouser ED, White P, Caceres EG, Julian MW, Papp AC, Locke LW, Sadee W, Schlesinger LS. A Novel In Vitro Human Granuloma Model of Sarcoidosis and Latent Tuberculosis Infection. Am J Respir Cell Mol Biol. 2017;57:487–498. - PMC - PubMed

Publication types

LinkOut - more resources